0,861  0,004  Antipsoriatic
0,859  0,003  Sensitization
0,855  0,009  Antiinflammatory
0,852  0,010  Apoptosis agonist
0,809  0,005  Bone diseases treatment
0,809  0,005  Respiratory analeptic
0,807  0,008  Antineoplastic (lung cancer)
0,767  0,011  Teratogen
0,763  0,013  Antineoplastic (breast cancer)
0,752  0,005  Antiosteoporotic
0,750  0,010  TNF expression inhibitor
0,750  0,011  Embryotoxic
0,727  0,011  Antileukemic
0,731  0,015  CYP3A4 substrate
0,707  0,009  Prostate cancer treatment
0,698  0,008  Analeptic
0,704  0,020  Transcription factor NF kappa B inhibitor
0,680  0,006  Nitric oxide antagonist
0,666  0,006  Antineoplastic (pancreatic cancer)
0,664  0,011  Antineoplastic (ovarian cancer)
0,647  0,005  Antineoplastic (endocrine cancer)
0,646  0,005  UGT1A4 substrate
0,651  0,013  Chemoprotective
0,639  0,007  Antipruritic, allergic
0,623  0,009  AR expression inhibitor
0,612  0,012  Immunosuppressant
0,607  0,020  CYP2C9 substrate
0,601  0,017  Carcinogenic
0,594  0,012  Immunomodulator
0,575  0,004  Contraceptive
0,575  0,005  Hair growth stimulant
0,577  0,014  Proliferative diseases treatment
0,580  0,025  Antineoplastic (colorectal cancer)
0,574  0,024  Antineoplastic (colon cancer)
0,550  0,003  Abortion inducer
0,562  0,017  Antineoplastic (melanoma)
0,564  0,018  CYP2C19 substrate
0,559  0,015  Chemopreventive
0,539  0,004  Interferon gamma antagonist
0,546  0,014  NOS2 expression inhibitor
0,512  0,004  UGT2B7 substrate
0,503  0,005  Antiacne
0,512  0,015  Antiparasitic
0,518  0,022  Cytotoxic
0,512  0,017  Antineoplastic (glioma)
0,497  0,003  UGT2B9 substrate
0,482  0,003  Antipruritic, non-allergic
0,484  0,011  Antihelmintic
0,518  0,053  Caspase 9 stimulant
0,477  0,015  UGT2B4 substrate
0,461  0,020  ICAM1 expression inhibitor
0,465  0,025  NOS3 expression inhibitor
0,449  0,011  Calcium channel activator
0,464  0,028  Hepatic disorders treatment
0,458  0,025  Cytostatic
0,444  0,016  Antineoplastic (liver cancer)
0,432  0,006  Lipocortins synthesis antagonist
0,426  0,004  Antieczematic
0,430  0,009  Prostate disorders treatment
0,436  0,017  UDP-glucuronosyltransferase substrate
0,447  0,029  Antineoplastic (cervical cancer)
0,403  0,012  Prostatic (benign) hyperplasia treatment
0,406  0,027  Antineoplastic (glioblastoma multiforme)
0,417  0,040  Antifungal
0,382  0,008  Antidiabetic (type 1)
0,393  0,019  Sodium/bile acid cotransporter inhibitor
0,376  0,014  Melanin inhibitor
0,363  0,006  Antifungal enhancer
0,379  0,035  Antineoplastic (multiple myeloma)
0,420  0,080  Antidiabetic
0,420  0,080  Cyclophilin D inhibitor
0,341  0,002  Hypercalcemia treatment
0,358  0,022  UGT1A1 substrate
0,345  0,012  Antiviral (Influenza A)
0,338  0,004  Farnesoid X receptor antagonist
0,361  0,028  DNA synthesis inhibitor
0,365  0,034  Antineoplastic (lymphoma)
0,339  0,010  Interleukin 6 antagonist
0,328  0,006  Androgen antagonist
0,317  0,003  Progesterone antagonist
0,348  0,039  Antineoplastic (osteosarcoma)
0,325  0,023  Hepatoprotectant
0,318  0,019  Pneumotoxic
0,330  0,031  Antineoplastic enhancer
0,383  0,085  Antibacterial
0,316  0,026  Antiviral (Influenza)
0,321  0,035  5 Hydroxytryptamine uptake stimulant
0,298  0,024  Antialcoholic
0,277  0,007  Contraceptive female
0,284  0,020  UGT2B15 substrate
0,308  0,046  Angiogenesis stimulant
0,315  0,053  Antihypoxic
0,265  0,005  Microtubule formation inhibitor
0,294  0,036  Platelet adhesion inhibitor
0,257  0,004  Antineoplastic alkaloid
0,273  0,021  Protein kinase stimulant
0,256  0,012  Expectorant
0,312  0,071  Antineoplastic (brain cancer)
0,242  0,001  Vitamin D receptor antagonist
0,305  0,065  Radioprotector
0,245  0,005  Actinic keratosis treatment
0,244  0,007  Arachidonic acid antagonist
0,249  0,013  UGT2B10 substrate
0,261  0,026  Carcinogenic, group 3
0,289  0,057  Antidiabetic symptomatic
0,232  0,002  Anabolic
0,287  0,058  Antineoplastic (renal cancer)
0,268  0,043  Anesthetic general
0,243  0,022  Antineoplastic (bone cancer)
0,235  0,014  Sulfotransferase substrate
0,280  0,059  Interleukin agonist
0,307  0,087  Cholesterol antagonist
0,245  0,026  Bone formation stimulant
0,247  0,031  Antineoplastic (carcinoma)
0,226  0,012  Choleretic
0,219  0,006  Vanilloid agonist
0,277  0,067  Antihypercholesterolemic
0,271  0,064  Antiprotozoal (Leishmania)
0,264  0,058  Antineoplastic (sarcoma)
0,207  0,004  UGT2B11 substrate
0,244  0,043  P-glycoprotein inhibitor
0,248  0,048  VCAM1 expression inhibitor
0,253  0,053  Antihypotensive
0,266  0,068  Tumour necrosis factor alpha release inhibitor
0,208  0,020  Antineoplastic antibiotic
0,194  0,011  Contraceptive male
0,275  0,094  CYP2D6 substrate
0,193  0,015  Mucolytic
0,195  0,018  Alcohol dehydrogenase substrate
0,190  0,014  Pregnane X receptor agonist
0,193  0,017  Adenylate cyclase stimulant
0,199  0,027  Cholesterol synthesis inhibitor
0,263  0,091  Immunostimulant
0,224  0,055  Non-steroidal antiinflammatory agent
0,228  0,059  Mutagenic
0,251  0,083  Antioxidant
0,176  0,009  SULT1E1 substrate
0,205  0,039  Toxic, respiratory center
0,232  0,067  Antiviral (HIV)
0,262  0,098  CTGF expression inhibitor
0,163  0,004  Glucocorticoid antagonist
0,236  0,076  Antineoplastic (lymphocytic leukemia)
0,165  0,006  5-Alpha-reductase inhibitor
0,181  0,023  Growth stimulant
0,258  0,110  Interleukin 2 agonist
0,159  0,012  Paget's disease treatment
0,189  0,043  Anesthetic
0,176  0,034  Antiviral (Hepatitis B)
0,149  0,008  Glycine receptor antagonist
0,258  0,117  Angiogenesis inhibitor
0,180  0,039  Skin irritative effect
0,258  0,120  Apoptosis antagonist
0,141  0,002  Parathyroid hormone antagonist
0,208  0,069  Neurotrophic factor enhancer
0,144  0,008  Hyperparathyroidism treatment
0,266  0,131  GST A substrate
0,163  0,029  SULT1A1 substrate
0,142  0,008  Na+ K+ transporting ATPase inhibitor
0,247  0,114  Caspase 3 stimulant
0,143  0,010  T cell inhibitor
0,178  0,046  Genotoxic
0,200  0,068  CYP2B6 inhibitor
0,160  0,029  Vanilloid 1 agonist
0,134  0,003  Postcoital contraceptive
0,152  0,022  Estrogen antagonist
0,228  0,100  Antineoplastic (bladder cancer)
0,129  0,003  CYP24 inhibitor
0,144  0,017  Transcription factor NF kappa B stimulant
0,145  0,019  ABCA1 expression enhancer
0,218  0,093  Cardiovascular analeptic
0,136  0,012  Estrogen agonist
0,131  0,009  Androgen agonist
0,186  0,064  Muscle relaxant
0,183  0,062  Antirickettsial
0,143  0,024  Antispirochetal
0,207  0,088  UGT1A6 substrate
0,152  0,037  Ca2+-transporting ATPase inhibitor
0,125  0,010  Anticholelithogenic
0,134  0,020  Inducible nitric-oxide synthase inhibitor
0,128  0,016  Aromatase inhibitor
0,164  0,057  Antineoplastic (squamous cell carcinoma)
0,112  0,007  Potassium channel Kv1.3 blocker
0,109  0,005  RNA-directed RNA polymerase stimulant
0,219  0,116  Cardioprotectant
0,109  0,006  SULT2A1 substrate
0,126  0,025  Antibiotic
0,291  0,196  Antineoplastic (solid tumors)
0,197  0,103  Peptidyltransferase inhibitor
0,109  0,016  Postmenopausal disorders treatment
0,227  0,137  GST M1-1 substrate
0,197  0,108  Antineoplastic (non-small cell lung cancer)
0,160  0,071  Antiviral (Herpes)
0,113  0,024  Keratolytic
0,137  0,051  Protein-tyrosine phosphatase 1B inhibitor
0,119  0,033  Estrogen receptor beta antagonist
0,105  0,021  Narcotic antagonist
0,162  0,078  Growth hormone agonist
0,107  0,024  Estrogen receptor alpha antagonist
0,157  0,078  UGT1A3 substrate
0,133  0,054  Autism spectrum disorders treatment
0,088  0,009  Lipocortins synthesis agonist
0,202  0,125  UGT1A9 substrate
0,084  0,011  Estrogen receptor alpha agonist
0,081  0,010  Anesthetic inhalation
0,134  0,064  Antihemorrhagic
0,080  0,011  Aldosterone antagonist
0,082  0,014  Estrogen receptor beta agonist
0,147  0,079  Acute respiratory distress syndrome (ARDS) treatment
0,085  0,017  Protein 50S ribosomal subunit inhibitor
0,128  0,062  DNA polymerase I inhibitor
0,092  0,026  Glycine receptor agonist
0,144  0,084  Eye irritation, high
0,156  0,096  Antineoplastic (gastric cancer)
0,120  0,061  Shock treatment
0,171  0,114  Antiparkinsonian, rigidity relieving
0,175  0,120  Aldehyde oxidase inhibitor
0,223  0,169  Inflammatory Bowel disease treatment
0,064  0,011  Microtubule stabilization
0,110  0,058  UGT2B1 substrate
0,213  0,162  Antithrombotic
0,058  0,008  2,3-Oxidosqualene-lanosterol cyclase inhibitor
0,056  0,006  Tubulin agonist
0,087  0,037  CDC25A inhibitor
0,068  0,019  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,179  0,134  RNA-directed DNA polymerase inhibitor
0,046  0,003  Progesterone receptor B antagonist
0,151  0,109  LDLR expression enhancer
0,058  0,019  Adenylate cyclase 1 inhibitor
0,121  0,084  Skin whitener
0,049  0,012  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,040  0,005  Progesterone agonist
0,086  0,051  Antiprotozoal activity enhancer
0,150  0,115  Antiviral (Hepatitis)
0,037  0,003  Vitamin D receptor agonist
0,079  0,045  Antitreponemal
0,105  0,072  Monophenol monooxygenase inhibitor
0,137  0,104  Uterine stimulant
0,047  0,014  Glucose-6-phosphate dehydrogenase inhibitor
0,037  0,005  Hedgehog signaling activator
0,109  0,078  Menstruation disorders treatment
0,146  0,116  Phospholipase C inhibitor
0,123  0,095  Cell wall synthesis inhibitor
0,087  0,059  Ornithine decarboxylase inhibitor
0,051  0,024  Estradiol 17 beta-dehydrogenase inhibitor
0,032  0,006  Corticosteroid-like
0,098  0,072  Topoisomerase I inhibitor
0,076  0,051  SULT1A2 substrate
0,034  0,008  Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor
0,106  0,081  Topoisomerase II inhibitor
0,025  0,001  Vitamin D-like
0,088  0,068  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,050  0,029  Cholesterol esterase inhibitor
0,025  0,004  Telomerase stimulant
0,098  0,082  GABA C receptor antagonist
0,080  0,064  Antiviral (Dengue virus)
0,042  0,027  Hypogonadism treatment
0,098  0,083  Antihypermotility
0,088  0,074  Posttraumatic stress disorder treatment
0,027  0,013  Vanilloid 2 agonist
0,020  0,007  Glucocorticoid agonist
0,056  0,043  Pregnane X receptor antagonist
0,029  0,018  11-Beta-hydroxysteroid dehydrogenase 2 inhibitor
0,078  0,066  Ca(v)3.1 blocker
0,140  0,131  Antimitotic
0,040  0,031  Kainate receptor agonist
0,104  0,096  Alpha-N-acetylglucosaminidase inhibitor
0,040  0,031  Cholesterol absorption inhibitor
0,022  0,015  Estrone sulfatase inhibitor
0,063  0,056  Glutamate (mGluR6) antagonist
0,119  0,114  Protein-tyrosine phosphatase inhibitor
0,006  0,004  Transcortin receptor antagonist
0,056  0,054  Antimycoplasmal
0,130  0,128  Movement disorders treatment
0,128  0,126  Sedative
0,047  0,046  Acyl-CoA dehydrogenase inhibitor
0,123  0,123  Antihelmintic (Nematodes)

